Skip to main content
. 2011 Oct 29;378(9802):1560–1571. doi: 10.1016/S0140-6736(11)60937-9

Table 1.

Baseline characteristics of participants randomly assigned according to treatment group in total and stratified according to risk group

All participants
Low-risk participants
Medium-risk participants
High–risk participants
Intervention group (n=568) Control group (n=283) Intervention group (n=148) Control group (n=73) Intervention group (n=263) Control group (n=131) Intervention group (n=157) Control group (n=79)
Demographics
Age (years) 50·1 (15·0) 49·1 (14·3) 46·5 (14·3) 47·6 (14·7) 50·5 (15·3) 49·3 (13·5) 52·7 (14·5) 50·1 (15·3)
Sex, female 330 (58%) 170 (60%) 82 (55%) 42 (58%) 160 (61%) 83 (63%) 88 (56%) 45 (57%)
Routine and manual occupations* 287 (51%) 149 (53%) 61 (41%) 26 (36%) 137 (52%) 65 (50%) 89 (57%) 58 (73%)
Currently in paid employment 350 (62%) 174 (61%) 112 (76%) 50 (68%) 158 (60%) 83 (63%) 80 (51%) 41 (52%)
Time off work for back pain 185 (53%) 90 (52%) 40 (36%) 12 (24%) 95 (60%) 51 (61%) 50 (63%) 27 (66%)
Back pain and function
RMDQ disability score 9·8 (5·6) 9·7 (5·8) 4·6 (3·5) 4·2 (3·3) 9·9 (4·5) 9·8 (4·8) 14·4 (4·6) 14·7 (4·4)
Back pain intensity 5·3 (2·2) 5·2 (2·2) 3·4 (1·6) 3·5 (1·7) 5·5 (1·7) 5·3 (1·8) 7·0 (1·8) 6·8 (2·0)
Duration of back pain
<1 month 97 (17%) 54 (19%) 25 (17%) 14 (19%) 44 (17%) 24 (18%) 28 (18%) 16 (20%)
1–3 months 124 (22%) 66 (23%) 31 (21%) 15 (21%) 61 (23%) 39 (30%) 32 (20%) 12 (15%)
3–6 months 81 (14%) 42 (15%) 19 (13%) 12 (16%) 38 (14%) 16 (12%) 24 (15%) 14 (18%)
6 months to 3 years 144 (25%) 65 (23%) 45 (30%) 21 (29%) 65 (25%) 27 (21%) 34 (22%) 17 (22%)
>3 years 122 (21%) 56 (20%) 28 (19%) 11 (15%) 55 (21%) 25 (19%) 39 (25%) 20 (25%)
Radiating leg pain 352 (62%) 178 (63%) 61 (41%) 28 (38%) 176 (67%) 89 (68%) 115 (73%) 61 (77%)
Radiating pain below knee 179 (32%) 93 (33%) 24 (16%) 10 (14%) 75 (29%) 47 (36%) 80 (51%) 36 (46%)
Psychological measures
PCS, catastrophising score 16·3 (10·8) 15·9 (11·1) 8·6 (5·8) 8·1 (6·5) 14·6 (8·1) 13·6 (8·1) 26·4 (10·6) 26·9 (10·3)
PCS ≥20 186 (33%) 89 (31%) 8 (5%) 4 (5%) 60 (23%) 28 (21%) 118 (75%) 57 (72%)
TSK, fear avoidance score 40·3 (6·1) 40·6 (6·3) 36·5 (4·9) 36·5 (5·8) 39·2 (5·0) 39·7 (4·7) 45·8 (5·0) 46·0 (5·7)
HADS, anxiety subscale 7·4 (4·1) 7·6 (4·0) 5·2 (2·9) 5·4 (3·3) 7·0 (3·7) 7·4 (3·7) 10·1 (4·2) 10·1 (3·8)
HADS, depression subscale 5·8 (4·1) 6·0 (4·1) 3·1 (2·7) 3·0 (2·5) 5·5 (3·3) 6·0 (3·8) 8·9 (4·3) 8·9 (3·7)
General health
Widespread pain 186 (33%) 104 (37%) 33 (22%) 16 (22%) 93 (35%) 56 (43%) 60 (38%) 32 (41%)
SF12, physical component 37·0 (10·4) 36·4 (10·6) 45·9 (8·6) 46·0 (9·1) 35·7 (9·5) 35·1 (8·6) 30·8 (7·6) 29·6 (8·2)
SF12, mental component 48·2 (11·9) 47·8 (11·7) 53·7 (7·3) 53·0 (8·1) 49·6 (11·5) 48·6 (11·3) 40·6 (12·5) 41·5 (12·3)

Data are mean score (SD) or number (%). RMDQ=Roland and Morris Disability Questionnaire. PCS=Pain Catastrophizing Scale. TSK=Tampa Scale of Kinesiophobia. HADS=Hospital Anxiety and Depression Scale. SF12=Short Form 12.

*

Based on major groups 5–9 of the UK Standard Occupation Classification (2000) for current or most recent paid employment (inclusive of 36 missing data [26 in intervention group and ten in control group]).

Responders who reported being currently in paid employment at baseline and taking time off during the 12 months before baseline.

Based on the American College of Rheumatology's definition.33